There was a greater proportion of IDH-wildtype glioblastomas and a lower proportion of oligodendrogliomas in gliomas with GC than in those without GC, suggesting that the manifestation of GC can help predict molecular markers. This evidence concerns the gene IDH1 and central nervous system cancer.